Literature DB >> 21271778

Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature.

Piero Farruggia1, Alessandra Macaluso, Serena Tropia, Floriana Di Marco, Delia Russo, Antonella Grigoli, Antonino Trizzino, Paolo D'Angelo.   

Abstract

Hepatopathy-thrombocytopenia syndrome (HTS) is a severe complication very similar to vein occlusive disease (VOD), also known as hepatic sinusoidal obstructive syndrome (SOS), characterized by fever, hepatopathy (hepatomegaly with abnormal liver function tests), ascites, weight gain, jaundice, and thrombocytopenia (platelet count less than 25 × 10(3)/μL). It has been generally observed in patients with Wilms tumor, and is commonly associated to administration of actinomycin D. We report three children with Wilms tumor, with severe HTS/SOS, but had a different outcome, in spite of vigorous supportive therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271778     DOI: 10.3109/08880018.2010.535118

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

1.  A Novel 3D Culture System for High-Throughput Hepatoxicity Screening.

Authors:  Timothy P Spicer; Virneliz Fernández Vega; Louis Scampavia; Lynsey Willetts; Michelle Vessels
Journal:  Bioprocess Int       Date:  2018-10-20

2.  Sinusoidal Obstruction Syndrome during Treatment for Wilms' Tumor: A Life-threatening Complication.

Authors:  Sidharth Totadri; Amita Trehan; Deepak Bansal; Richa Jain
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.